Dassault Systèmes acquires Medidata (2019)
French software giant Dassault Systèmes bought clinical-trial software company Medidata for about $5.8 billion. The purchase folded a major drug-trial data platform into a larger design-software portfolio.
Medidata became a unit of Dassault's life-sciences arm rather than a standalone public company.
Drug-development software kept consolidating into larger platforms spanning multiple research stages.
Mirrors the strategic logic here: combine tools used at different stages of drug research under a single owner.
